Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
23.4M
-
Shares change
-
-726K
-
Total reported value, excl. options
-
$82.9M
-
Value change
-
-$2.41M
-
Put/Call ratio
-
3.12
-
Number of buys
-
16
-
Number of sells
-
-31
-
Price
-
$3.54
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2021
75 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2021.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.4M shares
of 52.3M outstanding shares and own 44.83% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (3.21M shares), Roumell Asset Management, LLC (2.89M shares), VANGUARD GROUP INC (2.01M shares), Evermore Global Advisors, LLC (1.73M shares), DIMENSIONAL FUND ADVISORS LP (1.55M shares), BlackRock Inc. (1.53M shares), VIEX Capital Advisors, LLC (1.51M shares), FULLER & THALER ASSET MANAGEMENT, INC. (942K shares), and GEODE CAPITAL MANAGEMENT, LLC (346K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.